Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and ...

PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...

At the Cleveland Clinic, doctors are using a one-time gene-editing therapy that alters a patient’s own blood-forming stem cells to correct the genetic mutation responsible for the disease. Physicians ...

Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, ...

Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...

For individuals living with sickle cell disease (SCD), the transition from pediatric to adult care can be one of the most ...

Kennedy and Kendall Richmond are spending Christmas apart, but a bone marrow transplant may finally bring them together.

Chhattisgarh has screened 1.65 crore individuals for sickle cell disease as part of a national mission to eradicate the ...

The Focus on Sickle Cell Foundation (FoSCel) presented a Citation of Appreciation to the National Health Insurance Authority ...